Recently, the CDK9 inhibitor flavopiridol was shown to induce apoptosis in primary chronic lymphocytic leukemia by targeting CDK9, cyclin T1, AFF3/4 and MLLT1 [51]. The gene discussed is AFF3; the disease is B-cell chronic lymphocytic leukemia.